Literature DB >> 27332120

Conformational and Thermodynamic Landscape of GPCR Activation from Theory and Computation.

Sijia S Dong1, William A Goddard2, Ravinder Abrol3.   

Abstract

We present a hybrid computational methodology to predict multiple energetically accessible conformations for G protein-coupled receptors (GPCRs) that might play a role in binding to ligands and different signaling partners. To our knowledge, this method, termed ActiveGEnSeMBLE, enables the first quantitative energy profile for GPCR activation that is consistent with the qualitative profile deduced from experiments. ActiveGEnSeMBLE starts with a systematic coarse grid sampling of helix tilts/rotations (∼13 trillion transmembrane-domain conformations) and selects the conformational landscape based on energy. This profile identifies multiple potential active-state energy wells, with the TM3-TM6 intracellular distance as an approximate activation coordinate. These energy wells are then sampled locally using a finer grid to find locally minimized conformation in each energy well. We validate this strategy using the inactive and active experimental structures of β2 adrenergic receptor (hβ2AR) and M2 muscarinic acetylcholine receptor. Structures of membrane-embedded hβ2AR along its activation coordinate are subjected to molecular-dynamics simulations for relaxation and interaction energy analysis to generate a quantitative energy landscape for hβ2AR activation. This landscape reveals several metastable states along this coordinate, indicating that for hβ2AR, the agonist alone is not enough to stabilize the active state and that the G protein is necessary, consistent with experimental observations. The method's application to somatostatin receptor SSTR5 (no experimental structure available) shows that to predict an active conformation it is better to start from an inactive structure template based on a close homolog than to start from an active template based on a distant homolog. The energy landscape for hSSTR5 activation is consistent with hβ2AR in the role of the G protein. These results demonstrate the utility of the ActiveGEnSeMBLE method for predicting multiple conformations along the pathways for activating GPCRs and the corresponding energy landscapes, thereby providing detailed structural insights into the initial molecular events of GPCR function that are not easily accessible by experiments.
Copyright © 2016 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27332120      PMCID: PMC4919603          DOI: 10.1016/j.bpj.2016.04.028

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  43 in total

1.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

2.  3D structure prediction of TAS2R38 bitter receptors bound to agonists phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP).

Authors:  Jun Tan; Ravinder Abrol; Bartosz Trzaskowski; William A Goddard
Journal:  J Chem Inf Model       Date:  2012-07-13       Impact factor: 4.956

3.  Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.

Authors:  Rainer E Martin; Peter Mohr; Hans Peter Maerki; Wolfgang Guba; Christoph Kuratli; Olivier Gavelle; Alfred Binggeli; Stefanie Bendels; Rubén Alvarez-Sánchez; André Alker; Liudmila Polonchuk; Andreas D Christ
Journal:  Bioorg Med Chem Lett       Date:  2009-09-12       Impact factor: 2.823

4.  A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.

Authors:  B A Ozenberger; J R Hadcock
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

5.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

Review 6.  The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin.

Authors:  Aashish Manglik; Brian Kobilka
Journal:  Curr Opin Cell Biol       Date:  2014-02-17       Impact factor: 8.382

7.  Universal allosteric mechanism for Gα activation by GPCRs.

Authors:  Charles N J Ravarani; Dawei Sun; Tilman Flock; A J Venkatakrishnan; Melis Kayikci; Christopher G Tate; Dmitry B Veprintsev; M Madan Babu
Journal:  Nature       Date:  2015-07-06       Impact factor: 49.962

8.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

9.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

10.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more
  1 in total

1.  The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.

Authors:  Amirhossein Mafi; Soo-Kyung Kim; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-03       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.